A detailed history of Engineers Gate Manager LP transactions in Immunome Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 11,633 shares of IMNM stock, worth $127,963. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,633
Holding current value
$127,963
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.7 - $16.51 $136,106 - $192,060
11,633 New
11,633 $170,000
Q1 2024

May 15, 2024

BUY
$11.01 - $27.34 $116,001 - $288,054
10,536 New
10,536 $260,000

Others Institutions Holding IMNM

About Immunome Inc.


  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $133M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.